Castle Biosciences Inc (CSTL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,466 | -54,886 | -47,981 | -29,204 | -67,138 |
| Depreciation Amortization | 6,839 | 5,255 | 3,650 | 1,663 | 9,175 |
| Income taxes - deferred | -223 | 13 | 13 | 13 | -1,877 |
| Accounts receivable | -14,930 | -13,779 | -7,978 | -4,383 | -6,218 |
| Accounts payable and accrued liabilities | 5,707 | 2,693 | 3,071 | 3,896 | 582 |
| Other Working Capital | -6,630 | -14,296 | -11,494 | -11,647 | -7 |
| Other Operating Activity | 61,077 | 50,787 | 31,494 | 14,223 | 23,828 |
| Operating Cash Flow | $-5,626 | $-24,213 | $-29,225 | $-25,439 | $-41,655 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,575 | 1,307 | 8,562 | 19,917 | -134,689 |
| PPE Investments | -13,608 | -9,818 | -7,365 | -3,333 | -5,437 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -26,419 |
| Investing Cash Flow | $-16,183 | $-8,511 | $1,197 | $16,584 | $-166,545 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -142 | -106 | -70 | -35 | -122 |
| Common Stock Issued | 2,978 | 2,224 | 1,872 | 1,077 | 3,325 |
| Other Financing Activity | -5,134 | -1,119 | -848 | -314 | -1,688 |
| Financing Cash Flow | $-2,298 | $999 | $954 | $728 | $1,515 |
| Beginning Cash Position | 122,948 | 122,948 | 122,948 | 122,948 | 329,633 |
| End Cash Position | 98,841 | 91,223 | 95,874 | 114,821 | 122,948 |
| Net Cash Flow | $-24,107 | $-31,725 | $-27,074 | $-8,127 | $-206,685 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,626 | -24,213 | -29,225 | -25,439 | -41,655 |
| Capital Expenditure | -13,621 | -9,828 | -7,373 | -3,338 | -5,632 |
| Free Cash Flow | -19,247 | -34,041 | -36,598 | -28,777 | -47,287 |